Live feed
Filing
SC 13G/A
SC 13G/A0000947871-16-001753·ORBIMED ADVISORS LLC
Schedule 13G ownership disclosure
Cynapsus Therapeutics Inc.
Security class unavailable · CUSIP: 23257Y859
Event date: 2016-10-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-16-001753
- Form type
- SC 13G/A
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Dec 08, 2016
- Reporting period
- Oct 28, 2016
- Description
- Schedule 13G beneficial ownership